创伤后生长经验与血缘血造干细胞移植在患有无形性贫血的患者:一种定性研究
Xinrui Huang1, Yan Xu2, Yue Pan3
1Nursing Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
PloS one
|July 10, 2025
概括
血造干细胞移植用于无塑性贫血可能是创伤性的. 这项研究探讨了患者和工作人员的创伤后成长,确定了改善心理护理和生活质量的主题.
科学领域:
- 血液学 血液学 血液学
- 心理学 心理学 心理学
- 移植医学 移植医学
背景情况:
- 造血干细胞移植 (HSCT) 是治疗无塑性贫血的唯一方法.
- 亲属关系HSCT提供了更好的移植成功,但涉及严重的患者创伤.
- 了解移植后的心理变化对于改善患者护理至关重要.
研究的目的:
- 探索患有无形性贫血的患者经历亲属关系HSCT的创伤后生长经验.
- 确定这些患者的心理变化和应对机制.
主要方法:
- 一致的小样本策略与有目的的抽样.
- 与患者和医务人员进行面对面的半结构面试.
- 收集的语言和非语言数据的解释性现象学分析.
主要成果:
- 对六名患者和三名医务人员的分析揭示了四个总体主题和九个子主题.
- 确定了研究群体中创伤后生长的特定阶段和元素.
结论:
- 这项研究阐明了无塑性贫血亲属关系HSCT接受者的创伤后生长过程.
- 研究结果支持开发有针对性的心理干预措施,以改善患者的结果和生活质量.
更多相关视频
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.9K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.5K
相关概念视频
Bone Marrow Sampling and Transplants
504
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
504
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
